Evidence mounts for the efficacy of radioimmunotherapy for B-cell lymphomas.

AuthorsOliver W Press
JournalJournal of clinical oncology : official journal of the American Society of Clinical Oncology (J Clin Oncol) Vol. 26 Issue 32 Pg. 5147-50 (Nov 10 2008) ISSN: 1527-7755 [Electronic] United States
PMID18854559 (Publication Type: Comment, Editorial, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal
  • Antigens, CD20
  • ibritumomab tiuxetan
  • Antibodies, Monoclonal (adverse effects, therapeutic use)
  • Antigens, CD20 (analysis)
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Chemotherapy, Adjuvant
  • Disease-Free Survival
  • Evidence-Based Medicine
  • Humans
  • Lymphoma, B-Cell (drug therapy, immunology, pathology, radiotherapy)
  • Neoplasm Staging
  • Radioimmunotherapy
  • Radiotherapy, Adjuvant
  • Research Design
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: